BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20192576)

  • 1. Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma?
    Demirci U; Coskun U; Sancak B; Ozturk B; Bahar B; Benekli M; Buyukberber S
    Asian Pac J Cancer Prev; 2009; 10(6):1021-4. PubMed ID: 20192576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage-colony stimulating factor in patients with colorectal cancer.
    Mroczko B; Szmitkowski M; Okulczyk B; Piotrowski Z
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():110-1. PubMed ID: 11820563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors in colorectal cancer patients.
    Mroczko B; Szmitkowski M; Okulczyk B
    Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
    Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Granulocyte macrophage-colony stimulating factor (GM-CSF) in diagnosis and monitoring of non-small cell lung cancer].
    Mroczko B; Szmitkowski M; Furman M; Czygier M
    Pol Arch Med Wewn; 1998 Mar; 99(3):195-202. PubMed ID: 9760805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.
    Nebiker CA; Han J; Eppenberger-Castori S; Iezzi G; Hirt C; Amicarella F; Cremonesi E; Huber X; Padovan E; Angrisani B; Droeser RA; Rosso R; Bolli M; Oertli D; von Holzen U; Adamina M; Muraro MG; Mengus C; Zajac P; Sconocchia G; Zuber M; Tornillo L; Terracciano L; Spagnoli GC
    Clin Cancer Res; 2014 Jun; 20(12):3094-106. PubMed ID: 24737547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selected hematopoietic cytokines in patients with colorectal cancer].
    Mroczko B; Ławicki S; Szmitkowski M; Czygier M; Okulczyk B; Piotrowski Z
    Pol Merkur Lekarski; 2003 Nov; 15(89):416-9. PubMed ID: 14969133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns.
    Coşkun M; Kardelen F; Oygür N; Undar L; Savaş A; Yeğin O
    Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M
    Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients.
    Mroczko B; Szmitkowski M; Okulczyk B
    Clin Chem Lab Med; 2002 Apr; 40(4):351-5. PubMed ID: 12059074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer.
    Deng G; Hu P; Zhang J; Liu Q; Liang N; Xie J; Qiao L; Luo H; Xu D; Liu F; Yu X; Liu Z; Lv Y; Zhang J
    Oncotarget; 2016 Dec; 7(51):85142-85150. PubMed ID: 27835886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
    Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G
    Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
    Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B
    Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer.
    Mroczko B; Szmitkowski M; Niklinski J
    Clin Chem Lab Med; 1999 Oct; 37(10):959-62. PubMed ID: 10616749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.
    Liljefors M; Nilsson B; Mellstedt H; Frödin JE
    Cancer Immunol Immunother; 2008 Mar; 57(3):379-88. PubMed ID: 17676322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
    Conran N; Saad ST; Costa FF; Ikuta T
    Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.